Atlas Trials

An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis

Clinical trial NCT01609049 · COMPLETED

Trial details

NCT number
NCT01609049
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatitis C, Chronic
Start date
2011-12-07
Primary completion
2015-06-22
Enrollment
1496

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.